High Tower Advisors, LLC Omeros Corp Call Options Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 21, 2020	BUY	$9.03 - $19.72 $2,709 - $5,916	300 Added 150.0%	500 $0
Q3 2018 Nov 09, 2018	BUY	$17.73 - $26.69 $1,773 - $2,669	100 Added 100.0%	200 $2,000
Q1 2018 May 15, 2018	SELL	$9.0 - $20.16 $900 - $2,016	-100 Reduced 50.0%	100 $0
Q4 2017 Feb 14, 2018	SELL	$13.26 - $22.86 $2,652 - $4,572	-200 Reduced 50.0%	200 $0
Q3 2017 Nov 14, 2017	SELL	$19.76 - $24.9 $3,952 - $4,980	-200 Reduced 33.33%	400 $1,000
Q2 2017 Aug 14, 2017	BUY	N/A	600	600 $1,000

121

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $555M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.